Clinical trial
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving…
NCT00445497 · Clatterbridge Centre for Oncology, Other · Unknown status
Key facts
| NCT number | NCT00445497 |
|---|---|
| Title | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia |
| Official title | A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE] |
| Lead sponsor | Clatterbridge Centre for Oncology, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Lymphoma, Neutropenia, Psychosocial Effects of Cancer and Its Treatment, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | amoxicillin-clavulanate potassium, ciprofloxacin, psychosocial assessment and care, quality-of-life assessment |
| Enrollment | 400 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2010 |
| First posted | Mar 9, 2007 |
| Last update posted | Aug 12, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: